Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | PD184352 | 0.1 | uM | 1 | LIF | 213.5 | 50 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 1 | LIF | 98.5 | 50 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 1 | LIF | 85.0 | 59 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 1 | LIF | 76.0 | 65 | ||||
RA2159 | IKK16 | 2.0 | uM | 1 | LIF | 85.5 | 64 | ||||
RA2159 | JNK-IN-8 | 3.0 | uM | 1 | LIF | 76.0 | 35 | ||||
N2586 | 1 | LIF | 117.0 | 57 | |||||||
N2586 | PD184352 | 0.1 | uM | 1 | LIF | 121.5 | 54 | ||||
N2586 | Lestaurtinib | 0.3 | uM | 1 | LIF | 125.0 | 30 | ||||
N2586 | Ruxolitinib | 0.3 | uM | 1 | LIF | 123.0 | 61 | ||||
N2586 | Tofacitinib | 0.3 | uM | 1 | LIF | 116.0 | 51 | ||||
N2586 | IKK16 | 2.0 | uM | 1 | LIF | 111.5 | 52 | ||||
N2586 | JNK-IN-8 | 3.0 | uM | 1 | LIF | 106.0 | 32 | ||||
RA2159 | EGF | 100 | ng/mL | 1 | LIF | 134.0 | 50 | ||||
RA2159 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 1 | LIF | 83.5 | 50 | |
RA2159 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | LIF | 88.0 | 59 | |
RA2159 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | LIF | 106.0 | 69 | |
RA2159 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | LIF | 129.5 | 48 | |
RA2159 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 1 | LIF | 81.0 | 50 | |
RA2159 | JNK-IN-11 | 0.3 | uM | 1 | LIF | 72.0 | 57 | ||||
N2586 | EGF | 100 | ng/mL | 1 | LIF | 131.0 | 54 | ||||
N2586 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 1 | LIF | 150.0 | 47 | |
N2586 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | LIF | 112.5 | 50 | |
N2586 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | LIF | 146.5 | 66 | |
N2586 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | LIF | 177.0 | 59 |